Alliance for Therapies in Neuroscience Inaugural Symposium
New Possibilities: Neurodegenerative Disease and Innovative Tools for Therapy Development

We invite you to join us for the inaugural Alliance for Therapies in Neuroscience (ATN) symposium, a special event bringing together neuroscience communities across the Weill Neurohub (UCSF, UC Berkeley, University of Washington) and Roche/Genentech to explore applications for computational biology, CRISPR-based technologies, and other innovative tools for the discovery and development of therapies to treat neurodegenerative diseases. The program will provide an overview of the ATN and vision for the partnership, followed by keynote talks from Drs. Aviv Regev and Jennifer Doudna, as well as interactive breakout sessions to discuss possible future directions for ATN-funded research, and concludes with a networking reception.

Tuesday, June 21, 2022  |  UCSF Mission Bay

1:30pm | Opening Remarks

1:50pm | Keynote Address

Aviv Regev, PhD
Head and Executive Vice President,
Research and Early Development
Genentech

2:35pm | Interactive Breakout Sessions

Interactive discussions exploring therapeutic potentials in:
CRISPR and CNS Disorders - focus on neurodegeneration
Dementia - focus on microglia cell biology
Parkinson’s Disease - focus on aggregation and homeostasis
Amyotrophic Lateral Sclerosis - focus on protection and repair

4:00pm | Keynote Address

Jennifer Doudna, PhD
Nobel Laureate in Chemistry
Professor of Biochemistry, Biophysics and Structural Biology
University of California, Berkeley

4:45pm | Closing Remarks

5:00pm | Networking Reception 

Registration required. In-person* and virtual attendance available.
Please contact Shannon Warto for registration details (shannon.warto@ucsf.edu).

* In-person attendance subject to change in accordance with UCSF COVID-19 policies.